Capricor Therapeutics, Inc.
CAPR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $486,022 | $130,944 | $94,775 | $67,651 |
| - Cash | $11,287 | $14,695 | $9,603 | $34,885 |
| + Debt | $1,451 | $2,236 | $2,560 | $2,870 |
| Enterprise Value | $476,186 | $118,485 | $87,731 | $35,636 |
| Revenue | $22,270 | $25,178 | $2,551 | $245 |
| % Growth | -11.5% | 886.8% | 941.8% | – |
| Gross Profit | -$27,698 | -$11,270 | -$19,265 | $245 |
| % Margin | -124.4% | -44.8% | -755.1% | 100% |
| EBITDA | -$41,140 | -$23,009 | -$29,164 | -$20,693 |
| % Margin | -184.7% | -91.4% | -1,143% | -8,449.5% |
| Net Income | -$40,467 | -$22,288 | -$29,020 | -$20,023 |
| % Margin | -181.7% | -88.5% | -1,137.4% | -8,175.9% |
| EPS Diluted | -1.15 | -0.83 | -1.18 | -0.87 |
| % Growth | -38.6% | 29.7% | -35.6% | – |
| Operating Cash Flow | -$39,996 | -$25,597 | $4,917 | -$16,809 |
| Capital Expenditures | -$1,539 | -$2,048 | -$3,360 | -$1,196 |
| Free Cash Flow | -$41,535 | -$27,644 | $1,557 | -$18,006 |